Down-regulation of MT1 proteins have been observed in esophageal squamous cell carcinoma [85,86], hepatocellular carcinoma [39,87], papillary thyroid carcinoma [88], and prostate cancer [89], suggesting their role as tumor suppressor. Here, MT1H is linked to prostate cancer.